Published Date: 
Oct,2017
Total Pages: 
100
Categories: 
Biotechnology
Report Id: BVNSM1017

According to the market research engine analyst, the global VNS market is anticipated to grow at a steady rate and can post a CAGR of close to 100 pc during the forecast period. The availability of favorable reimbursement and insurance approval policies will drive the growth prospects for the global VNS market until the end of 2021. The availability of favorable reimbursement policies encourages a large range of specialists to utilize VNS devices and increase the investments made in the development of new technologies for the treatment of epilepsy and other cardiac indications. According to the market research analysis, many health systems are increasingly taking efforts to negotiate better prices on implantable medical devices to enforce reimbursement policies by encouraging provide chain system to drive down the prices of neuromodulation and VNS devices.

 

How Big is The Global Vagus Nerve Stimulation Market?

 

The analysts forecast global Vagus Nerve Stimulation Market for the mining sector to grow at a CAGR of 10% during the period 2016-2022.

 

The major driving factors of Vagus Nerve Stimulation Market are as follows:

 

  •     Increasing prevalence of neurological disorders
  •     Favorable reimbursement and insurance approval policies
  •     Rising demand for external VNS devices

 

The challenges factors of Vagus Nerve Stimulation Market are as follows:

 

  •     Stringent regulatory approvals and high cost of devices
  •     Complications related to VNS
  •     High maintenance and low battery lifetime

 

The trends factors of Vagus Nerve Stimulation Market are as follows:

 

  •     Shift of surgeons focus toward minimally invasive VNS procedures
  •     Next-generation therapies for nervous system disorders
  •     Application of VNS in other indications

 

The Vagus Nerve Stimulation Market is segmented on the lines of its productand regional. Based on productsegmentation it covers Implantable VNS devices and External VNS devices. The Vagus Nerve Stimulation Market on geographic segmentation covers various regions such as North America, Europe, Asia Pacific, and Rest of World. Each geographic market is further segmented to provide market revenue for select countries such as the U.S., Canada, U.K. Germany, China, Japan, India, and GCC countries.

 

This report provides:

 

This report covers the present scenario and the growth prospects of the global Vagus Nerve Stimulation Market for 2016-2022. To calculate the market size, the report considers the revenue generated from the sales of robotic pharmacy prescription systems.

 

REPORT SCOPE:

 

The scope of the report includes a detailed study of global and regional markets on Vagus Nerve Stimulation Market with the reasons given for variations in the growth of the industry in certain regions.

 

The report covers detailed competitive outlook including the market share and company profiles of the key participants operating in the global market. Key players profiled in the report include LivaNova, Enteromedics, ElectroCorea and Cerbomed. Company profile includes assign such as company summary, financial summary, business strategy and planning, SWOT analysis and current developments.
 
The Top Companies Report is intended to provide our buyers with a snapshot of the industry’s most influential players.

 

The Vagus Nerve Stimulation Market has been segmented as below:

 

By Product Analysis:

  •     Implantable VNS devices
  •     External VNS devices

 

By Regional Analysis:

  • North America
  • Europe
  • Asia-Pacific
  • Rest of World

 

Reasons to Buy this Report:
1) Obtain the most up to date information available on all Automotive air suspension market.
2) Identify growth segments and opportunities in the industry.
3) Facilitate decision making on the basis of strong historic and forecast of Vagus Nerve Stimulation Market data.
4) Assess your competitor’s refining portfolio and its evolution.

 

Customization:
We can offer you custom research reports as per client’s special requirements.

Chapter: 1 INTRODUCTION    
    1.1    KEY TAKE AWAYS    
    1.2    REPORT DESCRIPTION    
    1.3    MARKETS COVERED    
    1.4    STAKEHOLDERS    
    1.5    RESEARCH METHODOLOGY    
    1.5.1    MARKET SIZE    
    1.5.2    MARKET SHARE    
    1.5.3    KEY DATA POINTS FROM SECONDARY SOURCES    
    1.5.4    KEY DATA POINTS FROM PRIMARY SOURCES 

Chapter: 2 EXECUTIVE SUMMARY
2.1. CXO PERSPECTIVE

Chapter: 3 MARKET OVERVIEW
3.1. MARKET DEFINITION AND SCOPE
3.2. KEY FINDINGS

3.2.1. Top investment pockets
3.2.2. Top winning strategies

3.3. MARKET SHARE ANALYSIS/TOP PLAYER POSITIONING, 2016
3.4. PORTER’S FIVE FORCES ANALYSIS
3.5. MARKET DYNAMICS

3.5.1. Drivers
3.5.2. Restraints
3.5.3. Opportunities

Chapter: 4 GLOBAL VAGUS NERVE STIMULATION (VNS) MARKET, BY PRODUCT
4.1. OVERVIEW

4.1.1. Market size and forecast

4.2. IMPLANTABLE VNS DEVICES

4.2.1. Key market trends
4.2.2. Growth factors and opportunities
4.2.3. Market size and forecast

4.3. EXTERNAL VNS DEVICES

4.3.1. Key market trends
4.3.2. Growth factors and opportunities
4.3.3. Market size and forecast

Chapter: 5 GLOBAL VAGUS NERVE STIMULATION (VNS) MARKET, BY APPLICATION
5.1. OVERVIEW

5.1.1. Market size and forecast

5.2. DEPRESSION

5.2.1. Market size and forecast

5.3. EPILEPSY

5.3.1. Market size and forecast

5.4. MIGRAINE

5.4.1. Market size and forecast

Chapter: 6 GLOBAL VAGUS NERVE STIMULATION (VNS) MARKET, BY END USER
6.1. OVERVIEW

6.1.1. Market size and forecast

6.2. HOSPITALS

6.2.1. Market size and forecast

6.3. AMBULATORY SURGICAL CENTERS (ASCS)

6.3.1. Market size and forecast

6.4. OTHERS

6.4.1. Market size and forecast

Chapter: 7 GLOBAL VAGUS NERVE STIMULATION (VNS) MARKET, BY BIOMATERIAL
7.1. OVERVIEW

7.1.1. Market size and forecast

7.2. CERAMICS

7.2.1. Market size and forecast

7.3. METALLIC

7.3.1. Market size and forecast

7.4. POLYMERIC

7.4.1. Market size and forecast

Chapter: 8 GLOBAL VAGUS NERVE STIMULATION (VNS) MARKET, BY REGION
8.1. OVERVIEW

8.1.1. Market size and forecast

8.2. NORTH AMERICA

8.2.1. Key market trends
8.2.2. Key growth factors and opportunities
8.2.3. Market size and forecast

8.2.3.1. U.S. market size and forecast
8.2.3.2. Canada market size and forecast
8.2.3.3. Mexico market size and forecast

8.2.4. North America Vagus Nerve Stimulation Market by Product
8.2.5. North America Vagus Nerve Stimulation Market by Application 
8.2.6. North America Vagus Nerve Stimulation Market by End User 
8.2.7. North America Vagus Nerve Stimulation Market by Biomaterials 

8.3. EUROPE

8.3.1. Key market trends
8.3.2. Key growth factors and opportunities
8.3.3. Market size and forecast

8.3.3.1. Germany market size and forecast
8.3.3.2. France market size and forecast
8.3.3.3. UK market size and forecast
8.3.3.4. Italy market size and forecast
8.3.3.5. Spain market size and forecast
8.3.3.6. Rest of Europe market size and forecast

8.3.4. Europe Vagus Nerve Stimulation Market by Product
8.3.5. Europe Vagus Nerve Stimulation Market by Application
8.3.6. Europe Vagus Nerve Stimulation Market by End User
8.3.7. Europe Vagus Nerve Stimulation Market by Biomaterials

8.4. ASIA-PACIFIC

8.4.1. Key market trends
8.4.2. Key growth factors and opportunities
8.4.3. Market size and forecast

8.4.3.1. Japan market size and forecast
8.4.3.2. China market size and forecast
8.4.3.3. Australia market size and forecast
8.4.3.4. India market size and forecast
8.4.3.5. South Korea market size and forecast
8.4.3.6. Rest of Asia-Pacific market size and forecast

8.4.4. Asia-Pacific Vagus Nerve Stimulation Market by Product
8.4.5. Asia-Pacific Vagus Nerve Stimulation Market by Application
8.4.5. Asia-Pacific Vagus Nerve Stimulation Market by End User
8.4.5. Asia-Pacific Vagus Nerve Stimulation Market by Biomaterials

8.5. LAMEA

8.5.1. Key market trends
8.5.2. Key growth factors and opportunities
8.5.3. Market size and forecast

8.5.3.1. Brazil market size and forecast
8.5.3.2. Argentina market size and forecast
8.5.3.3. Venezuela market size and forecast
8.5.3.4. Saudi Arabia market size and forecast
8.5.3.5. South Africa market size and forecast
8.5.3.6. Rest of LAMEA market size and forecast

8.5.4. LAMEA Vagus Nerve Stimulation Market by Product
8.5.5. LAMEA Vagus Nerve Stimulation Market by Application
8.5.6. LAMEA Vagus Nerve Stimulation Market by end User
8.5.7. LAMEA Vagus Nerve Stimulation Market by Biomaterials

Chapter: 9 COMPANY PROFILES
9.1. MEDTRONIC PLC

9.1.1. Operating business segments
9.1.2. Business performance
9.1.3. Key strategic moves and developments

9.2. ELECTROCORE LLC

9.2.1. Operating business segments
9.2.2. Business performance
9.2.3. Key strategic moves and developments

9.3. LIVANOVA PLC

9.3.1. Operating business segments
9.3.2. Business performance
9.3.3. Key strategic moves and developments

9.4. BOSTON SCIENTIFIC CORPORATION

9.4.1. Operating business segments
9.4.2. Business performance
9.4.3. Key strategic moves and developments

9.5. ALEVA NEUROTHERAPEUTICS SA

9.5.1. Operating business segments
9.5.2. Business performance
9.5.3. Key strategic moves and developments

9.6. BIOCONTROL MEDICAL

9.6.1. Operating business segments
9.6.2. Business performance
9.6.3. Key strategic moves and developments

9.7. BIONESS INC.

9.7.1. Operating business segments
9.7.2. Business performance
9.7.3. Key strategic moves and developments

9.8. ENTEROMEDICS INC.

9.8.1. Operating business segments
9.8.2. Business performance
9.8.3. Key strategic moves and developments

9.9. NEVRO CORPORATION

9.9.1. Operating business segments
9.9.2. Business performance
9.9.3. Key strategic moves and developments

9.10. NEUROPACE INC.

9.10.1. Operating business segments
9.10.2. Business performance
9.10.3. Key strategic moves and developments

License Format Properties
Single User License The report will be emailed to you. The report is sent in PDF format. This is a single user license, allowing one specific user access to the product.
Multi User License The report will be emailed to you. The report is sent in PDF format. This is a 1-5 user license, allowing up to five users to have access to the product.
Corporate License The report will be emailed to you. The report is sent in PDF format. This is a 10+ user license, allowing up to 10+ users to have access to the product.
Mini Report License In this you will receive full report except the Company Profile section of this report. In this you will receive full report except the Company Profile section of this report.
Need More Information: 

Email: Sales@marketresearchengine.com

Toll Free No. : +1-855-984-1862

Call Us. : +91 86 05 657204